Evidence map›Paper›PMID 23093672›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.

Michael L Beshiri, Katherine B Holmes, William F Richter, Samuel Hess, Abul B M M K Islam, Qin Yan, Lydia Plante, Larisa Litovchick, Nicolas Gévry, Nuria Lopez-Bigas and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. JMJD family proteins in cancer and inflammation.Signal transduction and targeted therapy · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Michael L BeshiriDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, IL 60607, USA.
Katherine B Holmes
William F Richter
Samuel Hess
Abul B M M K Islam
Qin Yan
Lydia Plante
Larisa Litovchick
Nicolas Gévry
Nuria Lopez-Bigas
William G Kaelin
Elizaveta V Benevolenskaya
University of Illinois Chicago · USUniversité de Sherbrooke · CADana-Farber Cancer Institute · USHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESYale University · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
The RBP2/JARID1A/KDM5A Histone Demethylase as a Potential Drug Target in CancerR01CA076120 · NCI · DANA-FARBER CANCER INSTITUTE · PI KAELIN, WILLIAM G. · 1998 to 2015
$3.6M
RBP2 regulation through differential recruitment to genomic lociR01CA138631 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BENEVOLENSKAYA, ELIZAVETA V · 2010 to 2014
$1.6M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA076120NCI NIH HHS R01 CA138631NCRR NIH HHS UL1 RR024139
6 · The paper itself

Abstract

Epigenetic regulation underlies the robust changes in gene expression that occur during development. How precisely epigenetic enzymes contribute to development and differentiation processes is largely unclear. Here we show that one of the enzymes that removes the activating epigenetic mark of trimethylated lysine 4 on histone H3, lysine (K)-specific demethylase 5A (KDM5A), reinforces the effects of the retinoblastoma (RB) family of transcriptional repressors on differentiation. Global location analysis showed that KDM5A cooccupies a substantial portion of target genes with the E2F4 transcription factor. During ES cell differentiation, knockout of KDM5A resulted in derepression of multiple genomic loci that are targets of KDM5A, denoting a direct regulatory function. In terminally differentiated cells, common KDM5A and E2F4 gene targets were bound by the pRB-related protein p130, a DREAM complex component. KDM5A was recruited to the transcription start site regions independently of E2F4; however, it cooperated with E2F4 to promote a state of deepened repression at cell cycle genes during differentiation. These findings reveal a critical role of H3K4 demethylation by KDM5A in the transcriptional silencing of genes that are suppressed by RB family members in differentiated cells.

Indexed as

AnimalsCell DifferentiationChromatin ImmunoprecipitationE2F4 Transcription FactorEmbryonic Stem CellsGenes, cdcHistonesHumansLysineMethylationMiceMice, Inbred C57BLMultiprotein ComplexesProtein BindingRepressor ProteinsRetinoblastoma-Binding Protein 2E2F4 Transcription FactorHistonesKDM5A protein, humanKDM5A protein, mouseLysineMultiprotein ComplexesRepressor ProteinsRetinoblastoma-Binding Protein 2

Identifiers

PMID23093672
PMCPMC3494949
OpenAlexW1979981555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.